作者: Begoña Monge-Maillo , Rogelio López-Vélez
DOI: 10.1007/S40265-013-0133-0
关键词: Leishmania chagasi 、 Pentamidine 、 Leishmania donovani 、 Visceral leishmaniasis 、 Pharmacotherapy 、 Immunology 、 Medicine 、 Leishmania infantum 、 Leishmania 、 Virology 、 Leishmaniasis
摘要: Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and infantum (known chagasi in South America). The therapeutic options for VL are diverse depend on different factors, such the geographical area of infection, development resistance to habitual treatments, HIV co-infection, malnourishment other concomitant infections. This article provides an exhaustive review literature regarding studies published treatment VL, gives recommendations stratified according their level evidence, species implicated location infection.